Tepezza

Viridian Stock Flashes A Bullish Sign In Its Eye-Disease Battle With Amgen
Investors Business Daily
Mon, 12/16/24 - 11:30 am
Viridian Therapeutics
thyroid eye disease
veligrotug
Amgen
Tepezza
Viridian says thyroid eye disease drug effective in reducing symptoms
Reuters
Tue, 09/10/24 - 09:47 am
Viridian Therapeutics
thyroid eye disease
clinical trials
veligrotug
Tepezza
Amgen
Amgen's marketing efforts help boost Tepezza sales
Fierce Pharma
Wed, 08/7/24 - 11:27 am
Amgen
earnings
Tepezza
Amgen's new Horizon products bolster top line despite continued Tepezza struggles
Fierce Pharma
Fri, 05/3/24 - 11:23 am
Amgen
Horizon Pharma
Krystexxa
Tepezza
Innovent's Tepezza rival one step closer to Chinese approval after phase 3 eye disease win
Fierce Biotech
Tue, 02/20/24 - 05:51 pm
Innovent Biologics
thyroid eye disease
Tepezza
China
Amgen
IBI311
Amgen makes progress with its Horizon prize Tepezza, but there's much work left to do
Fierce Pharma
Wed, 02/7/24 - 09:22 pm
Amgen
Horizon Therapeutics
M&A
Tepezza
Key Horizon drug Tepezza has hearing loss warning added to labeling
Seeking Alpha
Thu, 07/20/23 - 09:46 pm
Horizon Therapeutics
Tepezza
hearing loss
thyroid eye disease
Viridian aims to prove itself in thyroid eye
EP Vantage
Thu, 04/20/23 - 10:41 am
Viridian Therapeutics
thyroid eye disease
Horizon Therapeutics
Tepezza
VRDN-001
Horizon's (HZNP) Tepezza Meets Goals in TED Expanded Use Study
Zacks.com
Tue, 04/11/23 - 11:28 am
Horizon Therapeutics
Tepezza
clinical trials
thyroid eye disease
Viridian takes on Horizon
EP Vantage
Tue, 08/16/22 - 10:49 am
Horizon Therapeutics
Virdian
thyroid eye disease
VRDN-001
Tepezza
Horizon lays out $65M for in-house manufacturing plant as eye med Tepezza resets course to blockbusterland
Fierce Pharma
Wed, 06/23/21 - 11:01 am
Horizon Therapeutics
drug manufactruing
Tepezza
thyroid eye disease
Horizon switched up strategy for Tepezza launch, moving quickly to DTC to reach eye disease patients
Fierce Pharma
Tue, 01/19/21 - 10:44 am
Horizon Pharma
thyroid eye disease
Tepezza
drug launches
DTC
FDA Approves First-Ever Treatment for Thyroid Eye Disease
Motley Fool
Tue, 01/21/20 - 11:50 pm
Horizon Therapeutics
Tepezza
thyroid eye disease
FDA